OQROGet OQRO Pro
Insider trade

ANI Pharmaceuticals, Inc. (ANIP)Officer sold ~$53K

Ori Gutwerg, Officer at ANI Pharmaceuticals, Inc., sold ~$53K of ANI Pharmaceuticals, Inc. shares.

~$53K
Approx. value · 881 sh @ $60.07
90K
Holds after · shares reported
Traded
May 15, 2025
Filed
May 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 19, 2025InsiderOfficer sold ~$121K of ANIP shares in the open market
  2. Apr 14, 2025InsiderOfficer sold ~$28K of ANIP shares in the open market
  3. May 9, 2025InsiderDirector sold ~$54K of ANIP shares in the open market
  4. May 13, 2025InsiderOfficer sold ~$25K of ANIP shares in the open market
  5. May 14, 2025InsiderOfficer sold ~$242K of ANIP shares in the open market
  6. May 15, 2025 · this disclosureInsiderOfficer sold ~$53K of ANIP shares in the open market

What came next

  1. Jun 13, 2025InsiderOfficer sold ~$25K of ANIP shares in the open market
  2. Jul 14, 2025InsiderOfficer sold ~$26K of ANIP shares in the open market
  3. Aug 12, 2025Insider · 5 peopleInsiders: 5 sales (~$11.8M)
  4. Aug 13, 2025InsiderOfficer sold ~$36K of ANIP shares in the open market
  5. Aug 14, 2025InsiderDirector sold ~$4.21M of ANIP shares in the open market
  6. Aug 15, 2025Insider · 3 peopleInsiders: 3 sales (~$7.2M)
  7. Aug 18, 2025Insider · 2 peopleInsiders: 3 sales (~$2.5M)
  8. Aug 20, 2025Insider · 2 peopleInsiders: 2 sales (~$4.7M)
  9. Aug 21, 2025InsiderDirector sold ~$4.79M of ANIP shares in the open market
  10. Aug 22, 2025InsiderOfficer sold ~$161K of ANIP shares in the open market
  11. Aug 25, 2025InsiderDirector sold ~$229K of ANIP shares in the open market
  12. Sep 3, 2025InsiderDirector sold ~$692K of ANIP shares in the open market
  13. Sep 8, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for ANI Pharmaceuticals, Inc.

For ANI Pharmaceuticals, Inc., OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANIP page.

Other recent filings by Ori Gutwerg, SVP, GENERICS

The full history of Ori Gutwerg, SVP, GENERICS is on the profile page.

How this filing works

Other disclosures at ANI Pharmaceuticals, Inc.

Everything OQRO holds on this company is on its ANIP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data